Important to carefully observe the science, reflecting on the strengths and weaknesses of all approaches. That is the scientific method.
This study was started in January 2021 until early 2022. Understanding the timeline is critical for realising this is a historical view of the pandemic during the delta wave. No surprise that some unvaccinated individuals had moderate to severe COVID-19 with associated thromboembolic disease.
In contrast, the Omicron phase would have been overall protective to most of the unvaccinated cohort, except if they had interferon autoantibodies.
COVID-19 vaccination reduced the risk of heart failure, venous thromboembolism and arterial thrombosis/thromboembolism in the acute (30 days) and post-acute (31 to 365 days) phase following SARS-CoV-2 infection. This effect was stronger in the acute phase.
Mercadé-Besora N, Li X, Kolde R, et al The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications, Heart Published Online First: 12 March 2024. doi: 10.1136/heartjnl-2023-323483
Please support my research efforts by subscribing to Vejon Health Substack. Your support allows me to continue bringing you my insights in a timely and effective way.
Covid Vaccine Reduces the Risk of Clots after Covid Infection!